Novacyl JA – 785
This Rx-360 Audit Report contains the following scope:
The scope of the audit was focused on the main processes of manufacturing, packaging,
labeling, testing and controls and warehousing of Salicylic Acid and Methyl Salicylate.
The audit was based on Rx-360 Audit standards for Active Pharmaceutical Ingredients
(APIs) and API Intermediates and included a supply chain security component based on the
Rx-360 Consortium Supply Chain Security Checklist.